Clinical trial

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in…

NCT00110760 · ZARS Pharma Inc., Industry · Completed

Key facts

NCT number NCT00110760
Title S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face
Official title Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream)for Induction of Local Dermal Anesthesia for Dermal Filler Injection on the Face of Adults
Lead sponsor ZARS Pharma Inc., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Pain
Intervention type Drug
Interventions S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%), Placebo Peel
Enrollment 70
Start date Jun 1, 2005
Primary completion Sep 1, 2005
Completion Sep 1, 2005
First posted May 13, 2005
Last update posted Jun 5, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies